Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: MINERALYS THERAPEUTICS, INC.
CIK: 1933414
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2023-05-15
Last Filing Date: 2025-05-12
SEC Filings
Start End Frame Filed ACCN Value View
2023-01-01 2023-03-31 CY2022Q1 2023-05-15 0001933414-23-000038 $ 24,764,469 View
2023-04-01 2023-06-30 CY2022Q2 2023-08-07 0001933414-23-000056 $ 39,754,981 View
2023-07-01 2023-09-30 CY2022Q3 2023-11-07 0001933414-23-000087 $ 184,000 View
2023-01-01 2023-12-31 CY2022 2024-03-21 0001628280-24-012358 $ 18,600,000 View
2023-02-14 2024-03-31 CY2024Q1I 2024-05-09 0001933414-24-000016 $ 51,000 View
2024-04-01 2024-06-30 CY2024Q2I 2024-08-13 0001933414-24-000039 $ 138,000 View
2024-07-01 2024-09-30 CY2024Q3 2024-11-12 0001933414-24-000057 $ -10,000 View
2024-01-01 2024-12-31 CY2024Q4I 2025-02-12 0001933414-25-000009 $ 15,600,000 View
2025-01-01 2025-03-31 CY2025Q1 2025-05-12 0001933414-25-000058 $ 12,509,000 View
SEC Facts By Type
Type Name Description View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Number of Operating Segments Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Temporary Equity, Shares Authorized The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, State and Local Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Debt Securities, Current Amount of investment in debt security measured at amortized cost (held-to-maturity), investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at fair value with change in fair value recognized in net income (trading); classified as current. View
us-gaap Defined Contribution Plan, Cost Amount of cost for defined contribution plan. View
us-gaap Defined Contribution Plan, Employer Matching Contribution, Percent of Match Percentage employer matches of the employee's percentage contribution matched. View
us-gaap Marketable Securities, Noncurrent Amount of investment in marketable security, classified as noncurrent. View
us-gaap Tax Credit Carryforward, Amount The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accretion (Amortization) of Discounts and Premiums, Investments The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. View
us-gaap Accrued Employee Benefits Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Professional Fees Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash Equivalents, at Carrying Value Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Common Stock, Capital Shares Reserved for Future Issuance Aggregate number of common shares reserved for future issuance. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Conversion of Stock, Amount Converted "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Deferred Offering Costs Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap 2738721 None View
us-gaap Increase (Decrease) in Accrued Interest Receivable, Net The increase (decrease) during the reporting period in the amount due from borrowers for interest payments. View
us-gaap Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other. View
us-gaap Interest Income (Expense), Nonoperating, Net The net amount of nonoperating interest income (expense). View
us-gaap Investments and Cash Sum of investments and unrestricted cash as of the balance sheet date. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Other Assets, Noncurrent Amount of noncurrent assets classified as other. View
us-gaap Other Nonoperating Income Amount of income related to nonoperating activities, classified as other. View
us-gaap Payments to Acquire Held-to-maturity Securities Amount of cash outflow through purchase of long-term held-to-maturity securities. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Issuance of Redeemable Convertible Preferred Stock The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder. View
us-gaap Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, Domestic Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards. View
us-gaap Restricted Cash Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Sale of Stock, Consideration Received on Transaction Cash received on stock transaction after deduction of issuance costs. View
us-gaap Sale of Stock, Price Per Share Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stockholders' Equity Note, Stock Split, Conversion Ratio Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Accrued Employee Benefits, Current Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Professional Fees, Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Current Income Tax Expense (Benefit) Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. View
us-gaap Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Tax Assets, Goodwill and Intangible Assets Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill. View
us-gaap Deferred Tax Assets, Other Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards, Research Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for option under share-based payment arrangement. View
us-gaap Debt Securities, Held-to-maturity, Fair Value Fair value of investment in debt security measured at amortized cost (held-to-maturity). View
us-gaap Income Tax Examination, Penalties and Interest Accrued The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations. View
us-gaap Proceeds from Issuance Initial Public Offering The cash inflow associated with the amount received from entity's first offering of stock to the public. View
us-gaap Proceeds from Stock Plans The cash inflow associated with the amount received from the stock plan during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, Employee Stock Ownership Plan Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP). View
us-gaap Unrecognized Tax Benefits Amount of unrecognized tax benefits. View
us-gaap Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. View
us-gaap Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. View
us-gaap Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. View
us-gaap Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security. View
us-gaap Payments to Acquire Productive Assets The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. View
us-gaap Proceeds from Issuance of Private Placement The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. View
us-gaap Proceeds from Issuance or Sale of Equity The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. View
us-gaap Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Stock Issued During Period, Value, Employee Stock Purchase Plan Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. View
us-gaap Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other. View
Chart of Accounts => Accounts
Name View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Operating Income (Loss) View
Other Assets, Noncurrent View
Deferred Tax Assets, Operating Loss Carryforwards, State and Local View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View
Debt Securities, Current View
Defined Contribution Plan, Cost View
Defined Contribution Plan, Employer Matching Contribution, Percent of Match View
Marketable Securities, Noncurrent View
Tax Credit Carryforward, Amount View
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs View
Accounts Payable, Current View
Accretion (Amortization) of Discounts and Premiums, Investments View
Accrued Employee Benefits View
Accrued Liabilities, Current View
Accrued Professional Fees View
Additional Paid in Capital View
Share-based Payment Arrangement, Expense View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Assets View
Assets, Current View
Cash View
Cash and Cash Equivalents, at Carrying Value View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Cash Equivalents, at Carrying Value View
Common Stock, Capital Shares Reserved for Future Issuance View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Conversion of Stock, Amount Converted View
Deferred Offering Costs View
Earnings Per Share, Basic View
Earnings Per Share, Diluted View
General and Administrative Expense View
Increase (Decrease) in Accounts Payable and Accrued Liabilities View
Increase (Decrease) in Accrued Interest Receivable, Net View
Increase (Decrease) in Prepaid Expense and Other Assets View
Interest Income (Expense), Nonoperating, Net View
Investments and Cash View
Liabilities and Equity View
Liabilities, Current View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Investing Activities View
Net Cash Provided by (Used in) Operating Activities View
Net Income (Loss) Attributable to Parent View
Nonoperating Income (Expense) View
Number of Operating Segments View
Operating Expenses View
Other Nonoperating Income View
Payments to Acquire Held-to-maturity Securities View
Prepaid Expense and Other Assets, Current View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Redeemable Convertible Preferred Stock View
Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities View
Research and Development Expense View
Restricted Cash View
Retained Earnings (Accumulated Deficit) View
Sale of Stock, Consideration Received on Transaction View
Sale of Stock, Price Per Share View
Share-based Payment Arrangement, Noncash Expense View
Stockholders' Equity Attributable to Parent View
Stockholders' Equity Note, Stock Split, Conversion Ratio View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Stock Issued During Period, Value, New Issues View
Temporary Equity, Shares Authorized View
Weighted Average Number of Shares Outstanding, Diluted View
Weighted Average Number of Shares Outstanding, Basic View
Proceeds from Stock Options Exercised View
Stock Issued During Period, Value, Stock Options Exercised View
Accrued Employee Benefits, Current View
Accrued Professional Fees, Current View
Current Income Tax Expense (Benefit) View
2714826 View
Deferred Income Tax Expense (Benefit) View
Deferred Tax Assets, Goodwill and Intangible Assets View
Deferred Tax Assets, Gross View
Deferred Tax Assets, Net of Valuation Allowance View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Operating Loss Carryforwards, Domestic View
Deferred Tax Assets, Other View
Deferred Tax Assets, Tax Credit Carryforwards, Research View
Deferred Tax Assets, Valuation Allowance View
Effective Income Tax Rate Reconciliation, Percent View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent View
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent View
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount View
Debt Securities, Held-to-maturity, Fair Value View
Income Tax Examination, Penalties and Interest Accrued View
Proceeds from Issuance Initial Public Offering View
Proceeds from Stock Plans View
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Employee Stock Ownership Plan View
Unrecognized Tax Benefits View
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions View
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions View
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Depreciation, Depletion and Amortization View
Payments of Stock Issuance Costs View
Payments to Acquire Productive Assets View
Proceeds from Issuance of Private Placement View
Proceeds from Issuance or Sale of Equity View
Property, Plant and Equipment, Net View
Stock Issued During Period, Value, Employee Stock Purchase Plan View
Other Nonoperating Income (Expense) View